Patents by Inventor Dror Avisar

Dror Avisar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12172916
    Abstract: The present invention provides systems and methods for treating liquids including contaminant molecules dispersed therein by combining physical treatment, biological treatment and/or chemical treatment.
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: December 24, 2024
    Assignee: Bio Castle Water Technologies Ltd.
    Inventors: Eyal Kurzbaum, Hadas Mamane, Ofir Menashe, Dror Avisar
  • Publication number: 20240352473
    Abstract: The present disclosure is directed to a novel sequence constructed from viral elements for use as a transgenic promoter; for example, in transgenic plants. More specifically, the present disclosure is directed to a chimeric transgenic promoter sequence comprising a portion derived from the Figwort Mosaic Vims (FMV/FiMV) genome and a portion derived from the Cassava Vein Mosaic Virus (CsVMV) genome. The present disclosure provides methods and compositions for the making and using such a transgenic promoter.
    Type: Application
    Filed: August 23, 2022
    Publication date: October 24, 2024
    Inventors: Dror Avisar, Shelly Azulay
  • Publication number: 20210047216
    Abstract: The present invention provides systems and methods for treating liquids including contaminant molecules dispersed therein by combining physical treatment, biological treatment and/or chemical treatment.
    Type: Application
    Filed: February 7, 2019
    Publication date: February 18, 2021
    Inventors: Eyal KURZBAUM, Hadas MAMANE, Ofir MENASHE, Dror Avisar
  • Patent number: 10407692
    Abstract: A nucleic acid expression vector comprising a nucleic acid sequence encoding a dominant negative T3SS protein is disclosed. The nucleic acid expression vector further comprising a cis acting regulatory element capable of driving transcription of the nucleic acid sequence in a plant cell. Moreover, the dominant negative T3SS protein mediates assembly of a dysfunctional needle complex.
    Type: Grant
    Filed: May 28, 2017
    Date of Patent: September 10, 2019
    Assignee: Futuragene Israel Ltd.
    Inventors: Hanan Stein, Dror Avisar
  • Patent number: 10155959
    Abstract: The present invention relates to the field of RNA-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species Bronze bug pest, Thaumastocoris peregrinus. In certain aspects, the invention provides Bronze bug nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as Bronze bug control agents.
    Type: Grant
    Filed: April 19, 2013
    Date of Patent: December 18, 2018
    Assignee: Futuragene Israel Ltd.
    Inventors: Dror Avisar, Daniel Siegel, Ziv Shani
  • Patent number: 9970022
    Abstract: The present invention relates to the field of RNA-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species gall wasp pests Leptocybe invasa (Li) and Ophelimus maskelli (Om). In certain aspects, the invention provides Li and Om nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as gall wasp control agents.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: May 15, 2018
    Assignee: Futuragene Israel Ltd.
    Inventors: Dror Avisar, Hanan Stein, Ziv Shani, Daniel Siegel
  • Publication number: 20180037907
    Abstract: The present invention relates to the field of RNA-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species Gb pest, Glycaspis brimblecombei. In certain aspects, the invention provides Gb nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as Gb control agents.
    Type: Application
    Filed: August 18, 2017
    Publication date: February 8, 2018
    Inventors: Dror Avisar, Daniel Siegel, Ziv Shani
  • Publication number: 20180016596
    Abstract: Nucleic acid constructs encoding Geraniol Synthase (GS), Geraniol Reductase (GR), Geraniol Dehydrogenase (GD), and/or Citral Reductase (CR) and plants comprising same are provided.
    Type: Application
    Filed: December 29, 2015
    Publication date: January 18, 2018
    Applicant: Futragene Israel Ltd.
    Inventors: Dror AVISAR, Miron ABRAMSON, Tany SINAI, Roee SHAVIT
  • Patent number: 9856492
    Abstract: A nucleic acid expression vector comprising a nucleic acid sequence encoding a dominant negative T3SS protein is disclosed. The nucleic acid expression vector further comprising a cis acting regulatory element capable of driving transcription of the nucleic acid sequence in a plant cell. Moreover, the dominant negative T3SS protein mediates assembly of a dysfunctional needle complex.
    Type: Grant
    Filed: March 1, 2012
    Date of Patent: January 2, 2018
    Assignee: Futuragene Israel Ltd.
    Inventors: Hanan Stein, Dror Avisar
  • Publication number: 20170260542
    Abstract: A nucleic acid expression vector comprising a nucleic acid sequence encoding a dominant negative T3SS protein is disclosed. The nucleic acid expression vector further comprising a cis acting regulatory element capable of driving transcription of the nucleic acid sequence in a plant cell. Moreover, the dominant negative T3SS protein mediates assembly of a dysfunctional needle complex.
    Type: Application
    Filed: May 28, 2017
    Publication date: September 14, 2017
    Applicant: Futuragene Israel Ltd.
    Inventors: Hanan STEIN, Dror AVISAR
  • Publication number: 20150259701
    Abstract: The present invention relates to the field of doublestranded RNA (dsRNA)-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species gall wasp pests Leptocybe invasa (Li) and Ophelimus maskelli (Om). In certain aspects, the invention provides Li and Om nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as gall wasp control agents.
    Type: Application
    Filed: October 2, 2013
    Publication date: September 17, 2015
    Applicant: Futuragene Israel Ltd.
    Inventor: Dror Avisar
  • Publication number: 20150082482
    Abstract: The present invention relates to the field of RNA-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species Bronze bug pest, Thaumastocoris peregrinus. In certain aspects, the invention provides Bronze bug nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as Bronze bug control agents.
    Type: Application
    Filed: April 19, 2013
    Publication date: March 19, 2015
    Applicant: Futuragene Israel Ltd.
    Inventors: Dror Avisar, Daniel Siegel, Ziv Shani
  • Publication number: 20150082490
    Abstract: The present invention relates to the field of RNA-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species Gb pest, Glycaspis brimblecombei. In certain aspects, the invention provides Gb nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as Gb control agents.
    Type: Application
    Filed: April 22, 2013
    Publication date: March 19, 2015
    Inventors: Dror Avisar, Daniel Siegel, Ziv Shani
  • Publication number: 20140157455
    Abstract: The present invention relates to the field of RNA-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species gall wasp pests Leptocybe invasa (Li) and Ophelimus maskelli (Om). In certain aspects, the invention provides Li and Om nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as gall wasp control agents.
    Type: Application
    Filed: March 30, 2012
    Publication date: June 5, 2014
    Applicant: FUTURAGENE ISRAEL LTD.
    Inventors: Dror Avisar, Hanan Stein, Ziv Shani, Daniel Siegel
  • Publication number: 20130347141
    Abstract: A nucleic acid expression vector comprising a nucleic acid sequence encoding a dominant negative T3SS protein is disclosed. The nucleic acid expression vector further comprising a cis acting regulatory element capable of driving transcription of the nucleic acid sequence in a plant cell. Moreover, the dominant negative T3SS protein mediates assembly of a dysfunctional needle complex.
    Type: Application
    Filed: March 1, 2012
    Publication date: December 26, 2013
    Applicant: FUTURAGENE ISRAEL LTD.
    Inventors: Hanan Stein, Dror Avisar
  • Publication number: 20130333073
    Abstract: Methods for improving the efficiency of photosynthesis in plants exposed to suboptimal light conditions. Photosynthesis enhancement is achieved by transformation and expression of one or more exogenous chromophores in the chloroplast of plants or in the cytoplasm under the control of a transit peptide which directs it to the chloroplast or a compartment within the chloroplast. Preferred chromophores have excitation max in the green-yellow light spectrum. Chains of chromophores can be used to capture and emit light from one to the other until the emitted wave length is in the range that can be efficiently utilize by the native light harvest complex.
    Type: Application
    Filed: June 7, 2013
    Publication date: December 12, 2013
    Inventors: Daniel Siegel, Dror Avisar, Miron Abramson, Ziv Shani, Stanley Hirsch
  • Publication number: 20130097731
    Abstract: An isolated polynucleotide is disclosed comprising: (i) a nucleic acid sequence encoding at least one toxic peptide, the toxic peptide being a spider toxin; and (ii) a nucleic acid sequence encoding a chitinase attached to a secretion signal sequence. Uses thereof and plants expressing same are also disclosed.
    Type: Application
    Filed: June 16, 2011
    Publication date: April 18, 2013
    Applicant: Futuragene Israel Ltd.
    Inventors: Dror Avisar, Hanan Stein, Ziv Shani
  • Publication number: 20110163045
    Abstract: Methods and systems for treatment, remediation, and purification of contaminated water at an optimal pH for are provided herein, as well as a database for use in said methods and systems. The methods and systems are based on identifying one or more contaminants in the contaminated water, and identifying an optimal pH for performing direct photodegradation of the contaminant(s).
    Type: Application
    Filed: September 7, 2009
    Publication date: July 7, 2011
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventors: Hadas Mamane, Dror Avisar, Yaal Lester, Igal Gozlan